loading
Precedente Chiudi:
$20.89
Aprire:
$20.245
Volume 24 ore:
949.00K
Relative Volume:
3.63
Capitalizzazione di mercato:
$838.21M
Reddito:
-
Utile/perdita netta:
$-81.05M
Rapporto P/E:
-8.0436
EPS:
-2.6232
Flusso di cassa netto:
$-68.97M
1 W Prestazione:
-7.46%
1M Prestazione:
-4.09%
6M Prestazione:
-23.19%
1 anno Prestazione:
+14.61%
Intervallo 1D:
Value
$20.00
$21.89
Intervallo di 1 settimana:
Value
$20.00
$23.26
Portata 52W:
Value
$15.47
$36.37

Arrivent Biopharma Inc Stock (AVBP) Company Profile

Name
Nome
Arrivent Biopharma Inc
Name
Telefono
240-780-6356
Name
Indirizzo
18 CAMPUS BLVD., NEWTOWN SQUARE
Name
Dipendente
52
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
AVBP's Discussions on Twitter

Confronta AVBP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AVBP
Arrivent Biopharma Inc
21.10 838.21M 0 -81.05M -68.97M -2.6232
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-20 Iniziato B. Riley Securities Buy
2025-03-10 Iniziato Guggenheim Buy
2024-07-22 Iniziato Oppenheimer Outperform
2024-04-30 Iniziato H.C. Wainwright Buy
2024-02-20 Iniziato Citigroup Buy
2024-02-20 Iniziato Goldman Buy
2024-02-20 Iniziato Jefferies Buy
Mostra tutto

Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie

pulisher
Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 07, 2025

Where are the Opportunities in (AVBP) - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Reduces Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Comparing Immutep (NASDAQ:IMMP) and ArriVent BioPharma (NASDAQ:AVBP) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of “Buy” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MyChesCo

Jun 02, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,327 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 30, 2025
pulisher
May 29, 2025

Promising Outlook for ArriVent BioPharma: Buy Rating Justified by Upcoming EGFR PACC Mutant NSCLC Program Updates - TipRanks

May 29, 2025
pulisher
May 29, 2025

Deutsche Bank AG Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 29, 2025
pulisher
May 25, 2025

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.5% – Here’s What Happened - Defense World

May 25, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Downgrades ArriVent BioPharma (NASDAQ:AVBP) to Strong Sell - Defense World

May 24, 2025
pulisher
May 22, 2025

ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jones Trading - Defense World

May 22, 2025
pulisher
May 20, 2025

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ArriVent BioPharma (AVBP) Coverage Initiated with 'Buy' Rating | - GuruFocus

May 20, 2025
pulisher
May 20, 2025

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with Optimistic Outlook | AVBP Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Purchases 10,498 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

May 20, 2025
pulisher
May 18, 2025

ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN

May 18, 2025
pulisher
May 18, 2025

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

May 18, 2025
pulisher
May 17, 2025

When the Price of (AVBP) Talks, People Listen - news.stocktradersdaily.com

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright - Defense World

May 17, 2025
pulisher
May 17, 2025

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $40.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Has $293,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 16, 2025
pulisher
May 16, 2025

B. Riley Lifts Earnings Estimates for ArriVent BioPharma - Defense World

May 16, 2025
pulisher
May 15, 2025

Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors - MyChesCo

May 15, 2025
pulisher
May 14, 2025

ArriVent BioPharma (AVBP) Receives Price Target Increase by HC W - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AV - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AVBP Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Voya Investment Management LLC Acquires Shares of 8,373 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 14, 2025
pulisher
May 14, 2025

Tower Research Capital LLC TRC Has $43,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 14, 2025
pulisher
May 12, 2025

ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2 - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2026 | AVBP Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent (AVBP) Advances Oncology Pipeline with Key Milestones Ahead | AVBP Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma Reports First Quarter 2025 Financial Results - The Manila Times

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma (AVBP) Expected to Announce Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 06, 2025

How to Take Advantage of moves in (AVBP) - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Arrivent Biopharma Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World

May 05, 2025
pulisher
May 04, 2025

ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World

May 04, 2025
pulisher
May 04, 2025

Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 04, 2025
pulisher
May 04, 2025

Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 04, 2025
pulisher
May 02, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 02, 2025
pulisher
May 01, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World

May 01, 2025
pulisher
May 01, 2025

Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 01, 2025

Arrivent Biopharma Inc Azioni (AVBP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):